FDA Announces Recall of Gas-X Softgels Due to Possible Contamination
The product recalled from the market comes from the manufacturer Haleon, which warned about a leak in the machinery during the manufacture of the drug.
The U.S. Food and Drug Administration (FDA) notified U.S. consumers this week via its website of the recall of Gas-X softgels due to possible contamination.
According to the health entity, the product recall by the manufacturer Haleon covers the batches of Gas-X Extra Strength 125 mg soft capsules, in containers of 120 and 72 units, which were intended for the relief of stomach pain and indigestion.
However, the manufacturer indicated that during the production of this medication there was a leak in the machinery that caused one of the diluted refrigerants based on propylene glycol to spill into the bottles, generating contamination in the drug.
Although propylene glycol is a substance commonly used in cosmetics and pharmacy, according to the FDA, contamination of Gas-X Extra softgels with this liquid can cause nausea, vomiting, abdominal pain and diarrhea.
In the statement, the entity detailed which lots are affected by the recall sold between April 13, 2026 and May 14, 2026:
So far, according to the manufacturer, no cases of poisoning have been reported due to the ingestion of this medication; However, the FDA recommended discarding the product or returning it to the store where you purchased it for a refund.

